Projects

IrsiCaixa is involved in a hundred national and international research projects active each year, funded by both public and private entities.

Keywords

Research group

Researcher

From date

To date

Glicoingeniería de nanovehículos para eliminar los reservorios virales; saf2017-91767-exp

Project status

Ongoing

Start/End

Principal investigator

Nuria Izquierdo Useros

Participating entities

Irsicaixa, ICN2, UPV-CSIC

Financing entity

MINECO
TISRESP - Tissue-resident memory cells as a potential immunotherapeutic target for combating mucosal infections

Project status

Ongoing

Start/End

2018

/

2023

Principal investigator

Cecilia Cabrera Navarro

Financing entity

Grifols
Glycoengineering nanovehicles to purge viral reservoirs

Project status

Ongoing

Start/End

2018

/

2021

Principal investigator

Nuria Izquierdo Useros

Participating entities

ICN2 and Biofisika-CISC

Financing entity

Spanish Ministry of Economy and Competitiveness, ref. SAF2017-91767-EXP.
HIV-specific immunity during treatment interruption (ATI) and its relationship to viral rebound and immune responses during acute HIV infection. New methos for ATI monituring in cure trials.

Project status

Ongoing

Start/End

2021

/

2023

Principal investigator

Beatriz Mothe Pujadas

Strategic lines

Immunopathology

Global infectious diseases

Therapies and vaccines

Financing entity

Ministerio de Ciencia, Innovación y Universidades - ISCIII

Fondo Europeo de Desarrollo Regional (FEDER)

Project Code PI20/01039

Team members: B. Mothe, A. Llano, S. Cedeño, M. Rosàs, T.Escribà, L. Bailón, Y. Alarcón.
Antiviral activity of Aplidin

Project status

Ongoing

Start/End

2020

/

2021

Principal investigator

Nuria Izquierdo Useros

Participating entities

IrsiCaixa, Animal Health Research Center (IRTA-CReSA)

Financing entity

Pharma Mar